Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | npj Vaccines | journal | 3.197 Q1 | 47 | 166 | 304 | 8553 | 2772 | 293 | 9.34 | 51.52 | 45.16 | |
2 | Journal of Biomedical Science | journal | 2.520 Q1 | 110 | 104 | 277 | 10355 | 3322 | 277 | 11.04 | 99.57 | 41.52 | |
3 | npj Breast Cancer | journal | 2.209 Q1 | 46 | 131 | 261 | 6079 | 1530 | 254 | 5.44 | 46.40 | 52.08 | |
4 | Drugs | journal | 2.093 Q1 | 188 | 146 | 521 | 9228 | 5194 | 502 | 9.73 | 63.21 | 35.53 | |
5 | Vaccines | journal | 1.655 Q1 | 85 | 2178 | 2497 | 113547 | 18817 | 2435 | 7.81 | 52.13 | 47.41 | |
6 | International Journal of Neuropsychopharmacology | journal | 1.406 Q1 | 125 | 96 | 224 | 5694 | 1192 | 216 | 4.93 | 59.31 | 39.88 | |
7 | CNS Neuroscience and Therapeutics | journal | 1.381 Q1 | 91 | 215 | 416 | 11129 | 2529 | 372 | 5.37 | 51.76 | 43.87 | |
8 | Antimicrobial Resistance and Infection Control | journal | 1.367 Q1 | 66 | 159 | 566 | 5684 | 3682 | 556 | 5.47 | 35.75 | 48.63 | |
9 | Therapeutic Advances in Infectious Disease | journal | 1.341 Q1 | 29 | 79 | 133 | 3336 | 565 | 112 | 4.18 | 42.23 | 45.19 | |
10 | Molecular Therapy - Oncolytics | journal | 1.339 Q1 | 42 | 154 | 420 | 9805 | 2379 | 420 | 5.60 | 63.67 | 40.14 | |
11 | Medicine in Drug Discovery | journal | 1.244 Q1 | 16 | 33 | 37 | 2959 | 260 | 34 | 7.34 | 89.67 | 40.00 | |
12 | Journal of Psychiatry and Neuroscience | journal | 1.220 Q1 | 114 | 51 | 181 | 2785 | 680 | 145 | 3.51 | 54.61 | 49.47 | |
13 | Biologics: Targets and Therapy | journal | 1.176 Q1 | 47 | 18 | 69 | 1241 | 349 | 69 | 4.29 | 68.94 | 32.53 | |
14 | Orphanet Journal of Rare Diseases | journal | 1.120 Q1 | 136 | 433 | 1140 | 17990 | 4502 | 1099 | 3.60 | 41.55 | 54.54 | |
15 | CPT: Pharmacometrics and Systems Pharmacology | journal | 1.119 Q1 | 55 | 132 | 316 | 4678 | 1172 | 291 | 3.22 | 35.44 | 40.12 | |
16 | Therapeutic Advances in Respiratory Disease | journal | 1.092 Q1 | 50 | 66 | 200 | 3170 | 833 | 189 | 4.31 | 48.03 | 39.96 | |
17 | Frontiers in Pharmacology | journal | 1.064 Q1 | 154 | 5709 | 7742 | 369866 | 44134 | 7564 | 5.39 | 64.79 | 45.29 | |
18 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.038 Q1 | 47 | 34 | 159 | 2431 | 694 | 159 | 4.41 | 71.50 | 32.75 | |
19 | OpenNano | journal | 1.005 Q1 | 21 | 71 | 7 | 7313 | 62 | 7 | 5.00 | 103.00 | 41.67 | |
20 | EJNMMI Radiopharmacy and Chemistry | journal | 0.972 Q1 | 28 | 33 | 97 | 1487 | 488 | 92 | 4.50 | 45.06 | 29.70 | |
21 | World Journal of Men?s Health | journal | 0.920 Q1 | 29 | 66 | 205 | 2777 | 1031 | 191 | 4.53 | 42.08 | 22.19 | |
22 | Infection and Drug Resistance | journal | 0.840 Q2 | 65 | 724 | 1399 | 27329 | 6112 | 1383 | 4.13 | 37.75 | 43.59 | |
23 | OncoTargets and Therapy | journal | 0.836 Q2 | 86 | 131 | 2593 | 6691 | 10334 | 2590 | 3.89 | 51.08 | 42.32 | |
24 | Infection and Chemotherapy | journal | 0.831 Q2 | 38 | 94 | 209 | 2902 | 712 | 193 | 3.76 | 30.87 | 47.48 | |
25 | Trials | journal | 0.814 Q2 | 98 | 1030 | 2718 | 41630 | 6431 | 2565 | 2.24 | 40.42 | 49.27 | |
26 | Cancer Chemotherapy and Pharmacology | journal | 0.811 Q2 | 122 | 129 | 624 | 4183 | 1952 | 614 | 2.94 | 32.43 | 42.91 | |
27 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.800 Q2 | 13 | 17 | 41 | 972 | 137 | 37 | 2.87 | 57.18 | 45.24 | |
28 | Vascular Health and Risk Management | journal | 0.798 Q2 | 82 | 86 | 189 | 3714 | 807 | 188 | 2.93 | 43.19 | 35.49 | |
29 | Antibiotics | journal | 0.792 Q2 | 77 | 1838 | 2748 | 110359 | 14048 | 2708 | 5.04 | 60.04 | 48.45 | |
30 | Cardiovascular Therapeutics | journal | 0.790 Q2 | 54 | 67 | 124 | 3211 | 463 | 124 | 3.09 | 47.93 | 40.63 | |
31 | Therapeutic Advances in Cardiovascular Disease | journal | 0.784 Q2 | 41 | 13 | 47 | 643 | 175 | 43 | 2.37 | 49.46 | 33.78 | |
32 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 31 | 138 | 1572 | 563 | 137 | 4.25 | 50.71 | 28.93 | |
33 | AIDS Research and Therapy | journal | 0.740 Q2 | 49 | 69 | 205 | 2803 | 520 | 205 | 2.25 | 40.62 | 49.85 | |
34 | Clinical Psychopharmacology and Neuroscience | journal | 0.740 Q2 | 42 | 84 | 231 | 3840 | 610 | 223 | 2.66 | 45.71 | 37.13 | |
35 | Journal of Cardiovascular Development and Disease | journal | 0.725 Q2 | 32 | 462 | 284 | 24006 | 899 | 281 | 2.47 | 51.96 | 37.42 | |
36 | Therapeutic Advances in Drug Safety | journal | 0.715 Q2 | 46 | 34 | 97 | 1643 | 352 | 82 | 3.71 | 48.32 | 53.85 | |
37 | Medical Cannabis and Cannabinoids | journal | 0.713 Q2 | 13 | 16 | 38 | 725 | 164 | 32 | 4.20 | 45.31 | 34.67 | |
38 | Drug Target Insights | journal | 0.690 Q2 | 16 | 13 | 15 | 522 | 62 | 14 | 2.90 | 40.15 | 36.54 | |
39 | Therapeutics and Clinical Risk Management | journal | 0.652 Q2 | 70 | 98 | 410 | 4366 | 1174 | 406 | 2.99 | 44.55 | 42.06 | |
40 | Neuropsychopharmacology Reports | journal | 0.651 Q2 | 22 | 76 | 165 | 2193 | 449 | 163 | 2.74 | 28.86 | 25.60 | |
41 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.650 Q2 | 57 | 33 | 201 | 1490 | 505 | 194 | 2.67 | 45.15 | 29.46 | |
42 | PharmacoEconomics - Open | journal | 0.646 Q2 | 20 | 74 | 197 | 3026 | 419 | 183 | 2.28 | 40.89 | 45.88 | |
43 | European Review for Medical and Pharmacological Sciences | journal | 0.634 Q2 | 88 | 1124 | 3881 | 38770 | 12480 | 3727 | 3.01 | 34.49 | 40.28 | |
44 | PPAR Research | journal | 0.631 Q2 | 59 | 15 | 68 | 1009 | 210 | 68 | 3.15 | 67.27 | 41.86 | |
45 | Australian Prescriber | journal | 0.624 Q2 | 40 | 79 | 192 | 848 | 225 | 89 | 1.07 | 10.73 | 56.25 | |
46 | BMC pharmacology & toxicology | journal | 0.603 Q2 | 43 | 93 | 246 | 3607 | 747 | 246 | 3.04 | 38.78 | 44.28 | |
47 | AIDS Reviews | journal | 0.593 Q2 | 62 | 29 | 85 | 1126 | 143 | 73 | 1.58 | 38.83 | 41.94 | |
48 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.568 Q2 | 46 | 47 | 97 | 2758 | 376 | 96 | 2.81 | 58.68 | 39.22 | |
49 | Drugs - Real World Outcomes | journal | 0.564 Q2 | 21 | 61 | 113 | 2190 | 227 | 110 | 1.99 | 35.90 | 44.58 | |
50 | Drug Metabolism and Pharmacokinetics | journal | 0.548 Q2 | 75 | 52 | 183 | 2281 | 442 | 178 | 2.26 | 43.87 | 32.81 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®